Axa
IAS

Axa’s Integral Ad Science IAS Stock Holding History

Axa’s Portfolio IAS Stock Details IAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-61,300
Closed -$882K – 1093
2023
Q4 		$882K Buy
+61,300
New +$820K ﹤0.01% 866

Other funds holding IAS

VEPM
Vista Equity Partners Management San Francisco, California $42.7M AUM 16.65% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sunriver Management Greenwich, Connecticut $591M AUM 2.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

Axa's IAS Position: Q1 2024 in Review

Axa sold out of Integral Ad Science (IAS) in Q1 2024, closing a stake of 61,300 shares — an estimated $882K sold.

Axa first reported a position in IAS in Q4 2023 and held it in 1 quarter. The position peaked at $882K in Q4 2023. 166 funds tracked by Wall St. Rank hold IAS as of Q1 2024.

  • Axa reported no remaining Integral Ad Science position as of Q1 2024 after selling out during the quarter.
  • Axa sold 61,300 Integral Ad Science shares in Q1 2024, an estimated $882K.
  • Axa first reported a position in Integral Ad Science in Q4 2023 and held it in 1 quarter.
  • Axa's Integral Ad Science position peaked at $882K in Q4 2023.
  • 166 funds tracked by Wall St. Rank held Integral Ad Science as of Q1 2024.

Based on Axa's 13F filing for Q1 2024, filed 15 May 2024.